Stovall, Dale W., Aqua, Keith, Roemer, Thomas, Donders, Gilbert, Sordal, Terje, Hauck, Brian, de la Llata, Eric Saucedo, Kallner, Helena Kopp, Salomon, Julie, Zvolanek, Michal, Frenz, Ann-Kathrin, Boehnke, Tanja and Bauerfeind, Anja (2021). Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena(R) satisfaction study. Eur. J. Contracept. Reprod. Health Care, 26 (6). S. 462 - 473. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1473-0782

Full text not available from this repository.

Abstract

Purpose The Kyleena(R) Satisfaction Study (KYSS) aimed to assess satisfaction and continuation with levonorgestrel-releasing intrauterine system (LNG-IUS) 12 (Kyleena(R)) in routine clinical practice and to evaluate factors that influence satisfaction. Materials and methods This prospective, observational, multicentre, single-arm cohort study, with 1-year follow-up, was conducted in Belgium, Canada, Germany, Mexico, Norway, Sweden, Spain and the United States from 2017 to 2018. During routine counselling, women who independently selected to use LNG-IUS 12 were invited to participate in the study. KYSS assessed LNG-IUS 12 satisfaction, continuation and safety. Results Overall, there were 1126 successful LNG-IUS 12 placements, with insertion attempted in 1129 women. Most participants (833/968, 86.1%, 95% CI 83.7-88.2%, with satisfaction outcome data available) reported satisfaction with LNG-IUS 12 at 12 months (or at the final visit if the device was discontinued prematurely). Satisfaction was not associated with age, parity or motivation for choosing LNG-IUS 12. The majority of women (919/1129, 81.4%) chose to continue after 12 months. Discontinuation was not correlated with age or parity. Overall, 191 women (16.9%) reported a treatment-emergent adverse event. Conclusions Results from KYSS provide the first real-world evidence assessing LNG-IUS 12, and demonstrate high satisfaction and continuation rates irrespective of age or parity.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Stovall, Dale W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Aqua, KeithUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Roemer, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Donders, GilbertUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sordal, TerjeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hauck, BrianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
de la Llata, Eric SaucedoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kallner, Helena KoppUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Salomon, JulieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zvolanek, MichalUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Frenz, Ann-KathrinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boehnke, TanjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bauerfeind, AnjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-598910
DOI: 10.1080/13625187.2021.1975268
Journal or Publication Title: Eur. J. Contracept. Reprod. Health Care
Volume: 26
Number: 6
Page Range: S. 462 - 473
Date: 2021
Publisher: TAYLOR & FRANCIS LTD
Place of Publication: ABINGDON
ISSN: 1473-0782
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
INTRAUTERINE CONTRACEPTIVE SYSTEMS; DEVICE; BARRIERS; WOMEN; RATES; DISCONTINUATION; EFFICACY; IMPLANT; SAFETY; TRIALMultiple languages
Public, Environmental & Occupational Health; Obstetrics & GynecologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/59891

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item